John Rondoni, Chief Technology Officer at Inspire Medical Systems, Inc. (INSP), sold 17,406 shares at $194.84 ($3.4M) on 2024-11-01, disclosed to the SEC on 2024-11-05.
Scheduled sale ($3.4M) by Chief Technology Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $192.93 | 5,777 | $1.1M | 33.1% |
| 2 | $192.93 | 5,777 | $1.1M | 33.1% |
| 3 | $193.92 | 1,580 | $306K | 9.1% |
| 4 | $193.92 | 1,580 | $306K | 9.1% |
| 5 | $194.84 | 1,013 | $197K | 5.9% |
| 6 | $194.84 | 1,013 |
| $197K |
| 5.9% |
| 7 | $196.42 | 333 | $65K | 1.9% |
| 8 | $196.42 | 333 | $65K | 1.9% |
| Total | $193.47 avg | 17,406 | $3.4M | 100% |
| Filing → |
| INSP | SELL | 2026-01-12 | $11K | — | Filing → |
| INSP | SELL | 2025-05-21 | $518K | — | Filing → |
| INSP | SELL | 2025-03-05 | $849K | — | Filing → |